PURPOSE:Cancer patients frequently suffer from psychological comorbidities such as depression and elevated stress. Previous studies could demonstrate that cancer patients benefit from massage therapy on the physical and psychological level. This pilot study investigates the effects of massage on depression, mood, perceived stress, and the Th1/Th2 ratio in breast cancer patients. METHODS:Thirty-four breast cancer patients were randomly assigned to a massage group (n=17) and a control group (n=17). Patients of the massage group received two 30-min classical massages per week for 5 weeks. At baseline, at the end of the intervention period, and 6 weeks after the end of intervention, patients of both groups completed the Perceived Stress Questionnaire (PSQ), the Patient Health Questionnaire (PHQ), and the Berlin Mood Questionnaire (BFS) and blood was withdrawn for determining cytokine concentrations and the Th1/Th2 ratio. RESULTS:Twenty-nine patients were included in the statistical analysis. Depression (PHQ) and anxious depression (BSF) were significantly reduced immediately after massage compared to the control group. Stress (PSQ) and elevated mood (BSF) did not show significant alterations after massage therapy. Changes of cytokine concentrations and Th1/Th2 ratio were insignificant as well, although there was a slight shift towards Th1 in the massage group over time. CONCLUSIONS:Massage therapy is an efficient treatment for reducing depression in breast cancer patients. Insignificant results concerning immunological parameters, stress, and mood indicate that further research is needed to determine psychological and immunological changes under massage therapy.
RCT Entities:
PURPOSE:Cancerpatients frequently suffer from psychological comorbidities such as depression and elevated stress. Previous studies could demonstrate that cancerpatients benefit from massage therapy on the physical and psychological level. This pilot study investigates the effects of massage on depression, mood, perceived stress, and the Th1/Th2 ratio in breast cancerpatients. METHODS: Thirty-four breast cancerpatients were randomly assigned to a massage group (n=17) and a control group (n=17). Patients of the massage group received two 30-min classical massages per week for 5 weeks. At baseline, at the end of the intervention period, and 6 weeks after the end of intervention, patients of both groups completed the Perceived Stress Questionnaire (PSQ), the Patient Health Questionnaire (PHQ), and the Berlin Mood Questionnaire (BFS) and blood was withdrawn for determining cytokine concentrations and the Th1/Th2 ratio. RESULTS: Twenty-nine patients were included in the statistical analysis. Depression (PHQ) and anxious depression (BSF) were significantly reduced immediately after massage compared to the control group. Stress (PSQ) and elevated mood (BSF) did not show significant alterations after massage therapy. Changes of cytokine concentrations and Th1/Th2 ratio were insignificant as well, although there was a slight shift towards Th1 in the massage group over time. CONCLUSIONS: Massage therapy is an efficient treatment for reducing depression in breast cancerpatients. Insignificant results concerning immunological parameters, stress, and mood indicate that further research is needed to determine psychological and immunological changes under massage therapy.
Authors: Jean S Kutner; Marlaine C Smith; Lisa Corbin; Linnea Hemphill; Kathryn Benton; B Karen Mellis; Brenda Beaty; Sue Felton; Traci E Yamashita; Lucinda L Bryant; Diane L Fairclough Journal: Ann Intern Med Date: 2008-09-16 Impact factor: 25.391
Authors: Thomas Pollmächer; Monika Haack; Andreas Schuld; Abraham Reichenberg; Raz Yirmiya Journal: Brain Behav Immun Date: 2002-10 Impact factor: 7.217
Authors: T A Ahles; D M Tope; B Pinkson; S Walch; D Hann; M Whedon; B Dain; J E Weiss; L Mills; P M Silberfarb Journal: J Pain Symptom Manage Date: 1999-09 Impact factor: 3.612
Authors: Rüya-Daniela Kocalevent; Susan Levenstein; Herbert Fliege; Gabriele Schmid; Andreas Hinz; Elmar Brähler; Burghard F Klapp Journal: J Psychosom Res Date: 2007-07 Impact factor: 3.006
Authors: Jun J Mao; Karen E Wagner; Christina M Seluzicki; Audra Hugo; Laura K Galindez; Heather Sheaffer; Kevin R Fox Journal: J Oncol Pract Date: 2017-01-03 Impact factor: 3.840
Authors: Heather Greenlee; Lynda G Balneaves; Linda E Carlson; Misha Cohen; Gary Deng; Dawn Hershman; Matthew Mumber; Jane Perlmutter; Dugald Seely; Ananda Sen; Suzanna M Zick; Debu Tripathy Journal: J Natl Cancer Inst Monogr Date: 2014-11
Authors: Becky Kinkead; Pamela J Schettler; Erika R Larson; Dedric Carroll; Margaret Sharenko; James Nettles; Sherry A Edwards; Andrew H Miller; Mylin A Torres; Boadie W Dunlop; Jeffrey J Rakofsky; Mark Hyman Rapaport Journal: Cancer Date: 2017-10-17 Impact factor: 6.860
Authors: Heather Greenlee; Melissa J DuPont-Reyes; Lynda G Balneaves; Linda E Carlson; Misha R Cohen; Gary Deng; Jillian A Johnson; Matthew Mumber; Dugald Seely; Suzanna M Zick; Lindsay M Boyce; Debu Tripathy Journal: CA Cancer J Clin Date: 2017-04-24 Impact factor: 508.702